← Back to Search

Behavioural Intervention

PROWESS Supportive Care for Prostate Cancer

Waitlist Available
Led By Daniel Lage, MD
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Screening 3 weeks
Treatment Varies
Follow Up at baseline and weeks 12-14
Awards & highlights


This trial seeks to improve quality of life for Black & Hispanic/Latino prostate cancer patients through exercise, reduced side effects of ADT & health behavior change tools.

Who is the study for?
The PROWESS trial is for Black and Hispanic/Latino men over 18 with prostate cancer, who've been on ADT for at least three months. Participants should exercise less than 150 minutes per week, have access to a smartphone or computer with Bluetooth, and be fluent in English or Spanish. Those with significant health issues preventing informed consent, current chemotherapy treatment, short prognosis, or unable to do physical activity are excluded.Check my eligibility
What is being tested?
PROWESS is a behavioral change intervention aimed at increasing exercise among participants to reduce side effects from ADT and improve their quality of life. It involves using wearable technology and structured support tools integrated into the participant's healthcare routine.See study design
What are the potential side effects?
Since PROWESS focuses on behavior change rather than medication, typical drug-related side effects aren't expected. However, increased physical activity could lead to muscle soreness or strain especially if participants are not accustomed to regular exercise.


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at baseline and weeks 12-14
This trial's timeline: 3 weeks for screening, Varies for treatment, and at baseline and weeks 12-14 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Participant Satisfaction
Secondary outcome measures
Change in Objective Physical Activity
Change in Participant Distress
Change in Participant Quality of Life
+1 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: PROWESSExperimental Treatment1 Intervention
Participants will complete study procedures as outlined: Wear FitBit watch during the 12-week study period. Group intervention sessions, in-person or virtually. Two, optional follow-up sessions. One-on-one, semi-structured interview with trained study staff to assess participant experience with intervention.

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor
2,955 Previous Clinical Trials
13,212,668 Total Patients Enrolled
34 Trials studying Prostate Cancer
2,968 Patients Enrolled for Prostate Cancer
Daniel Lage, MDPrincipal InvestigatorMassachusetts General Hospital

Media Library

PROWESS (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05755490 — N/A
Prostate Cancer Research Study Groups: PROWESS
Prostate Cancer Clinical Trial 2023: PROWESS Highlights & Side Effects. Trial Name: NCT05755490 — N/A
PROWESS (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05755490 — N/A
~4 spots leftby Jul 2025